Key Findings
The North America medical radiation detection and monitoring market is forecasted to rise with a CAGR of 6.79% between the forecasting period of 2019-2027, generating the highest revenue of $XX million by the end of 2027. The growing awareness of safety is increasing the adoption of medical radiation detection and monitoring devices to reduce the risk associated with exposure to high levels of radiation. The hastened adoption of radiation detection & monitoring devices is primarily driving the North America medical radiation detection and monitoring market.

Market Insights
The fact that nuclear medicine and radiation therapy is widely being used for diagnosis and treatment for cancer is majorly driving the market growth in this region. This is aided by the fact that increasing awareness and regulations in radiation-prone workplaces are being created for public health safety. The market is chiefly segmented based on products and end-users. Presently, hospitals are the primary end-users for this market.

North America market mainly includes countries such as the United States and Canada. The medical radiation detection and monitoring devices are mainly used in the specialty centers, diagnostic centers and hospitals. Nuclear medicine is being majorly deployed in the United States have received treatment considering nuclear medicine. Nuclear medicine utility has also been on the up-surging trend in Canada owing to the rising incidences of cancer.

Competitive Insights
Pro Protecx Medical, AADCO Medical, Inc., Amray Medical, Infab Corporation, Kromek Group PLC, Unfors RaySafe, Sun Nuclear Corporation, Protech Medical, Thermo Fisher Scientific Inc., Mirion Technologies, Fluke Biomedical LLC, Burlington Medical Supplies Inc., LANDAUER Inc., Radiation Detection Company Inc., and Bar-Ray are some of the leading players in this market.